I came across the following on the Kennedy’sDisease – Raising Awareness Facebook page:
I
have been taking Acetyl L-Carnitine since September and have seen a dramatic
improvement in the reduction of muscle fatigue, resulting in greater activity
and better health overall. I started with L-Carnitine at 500 mg to see if there
were any side effects, then after one month I switched to Acetyl L-Carnitine
(which crosses the blood/brain barrier), again 500mg to start then 1000. Its
hard to quantify what 'better' is in our lives,
but.... so far this month, I have built 12' of cabinets in the dining room,
built a 15x16ft glass greenhouse at the end of the drive and moved two pallets
of brick pavers and two yards of soil. All jobs that have been waiting for
several years.
There was also a link to the
study and I have posted that below.
First, I must qualify myself. I
am not a doctor or medical student. So, any comments are strictly of a layman
with an interest. In reading the article, I noticed it was not a study. This
article reported the findings in studying one patient with KD. It proposes
the possibility of this regiment in helping improve energy (reducing muscle
fatigue). The article proposes a more complete study to determine if the initial findings can be duplicated.
When there was a lot of
excitement from other Facebook members wanting to give this a try, the
gentleman responded with the following caution.
Please, everyone, little steps.... no one
gains if you break your leg running to the store. Try a small dose in the
morning with food if you like for a few days. It is expected to help with
muscle fatigue only, so that means embarking on some activity as well. The aim
is to feel better; not eliminate the disease. Too much too soon and you may
experience side effects that remove it as a therapeutic tool.
This is sound advice. One patient
doesn’t make a study. IMPORTANT: Always consult with your primary doctor and your neurologist before beginning any supplements, especially in high dosages.
Of course, anyone with SBMA wants to know more, so I looked up the definition:
Of course, anyone with SBMA wants to know more, so I looked up the definition:
Mitochondria: Structures located in the
cell's cytoplasm
outside the nucleus. Mitochondria are responsible for energy production. Each
consists of two sets of membranes: a smooth, continuous outer coat and an inner
membrane arranged in tubules or in folds that form plate-like double membranes
(cristae). The mitochrondria are the principal energy source of the cell. They
not only convert nutrients into energy but also perform many other specialized
tasks. Each mitochondrion
has a chromosome that is made of DNA but is otherwise quite different from the
better-known chromosomes in the nucleus. The mitochondrial chromosome is much
smaller than other chromosomes. It is round, whereas the chromosomes in the
nucleus are shaped like rods. There are many copies of the mitochondrial
chromosome in every cell, whereas there is normally only one set of chromosomes
in the nucleus. All mitochondrial chromosomes are inherited from the mother.
I also looked up possible side effects for this supplement and this is what I found at WebMid.
Acetyl-L-carnitine is LIKELY SAFE for most adults. It can cause some side effects including stomach upset, nausea, vomiting, and restlessness. It can cause a "fishy" odor of the urine, breath, and sweat.
Under-active thyroid (hypothyroidism): There is some concern that acetyl-L-carnitine might interfere with thyroid hormone. Don’t use acetyl-L-carnitine if you have an under-active thyroid.
Seizures: An increase in the number or seriousness of seizures has been reported in people with a history of seizures who have used L-carnitine by mouth or by IV (intravenously). Since L-carnitine is related to acetyl-L-carnitine, there is a concern that this might also occur with acetyl-L-carnitine. If you have ever had a seizure, don’t take acetyl-L-carnitine.
Mitochondrial impairment and elevated oxidative stress have been implicated in the pathogenesis of Kennedy’s disease. However, there is still no study describing the mitochondrial nutrient management in patients with Kennedy’s disease.
Methods
We assessed the clinical and electrophysiological features in a patient with Kennedy’s disease. This patient was diagnosed by genetic analysis. We also measured the plasma 8-hydroxydeoxyguanosine (8-OHdG) levels of the patient and his family members using commercial enzyme-linked immunosorbent assay (ELISA). Treatment with intravenous L-carnitine (2 g/day) for the patient was started on admission, followed by two weeks.
-
Under-active thyroid (hypothyroidism): There is some concern that acetyl-L-carnitine might interfere with thyroid hormone. Don’t use acetyl-L-carnitine if you have an under-active thyroid.
Seizures: An increase in the number or seriousness of seizures has been reported in people with a history of seizures who have used L-carnitine by mouth or by IV (intravenously). Since L-carnitine is related to acetyl-L-carnitine, there is a concern that this might also occur with acetyl-L-carnitine. If you have ever had a seizure, don’t take acetyl-L-carnitine.
_________________________
Mitochondrial dysfunction in Kennedy’s disease: a new
pharmacological target?
Chong Wang,
Wei Chen,
Dan Miao,
Jin-Tai Yu,
and Lan
Tan
Abstract
Background
Mitochondrial impairment and elevated oxidative stress have been implicated in the pathogenesis of Kennedy’s disease. However, there is still no study describing the mitochondrial nutrient management in patients with Kennedy’s disease.
We assessed the clinical and electrophysiological features in a patient with Kennedy’s disease. This patient was diagnosed by genetic analysis. We also measured the plasma 8-hydroxydeoxyguanosine (8-OHdG) levels of the patient and his family members using commercial enzyme-linked immunosorbent assay (ELISA). Treatment with intravenous L-carnitine (2 g/day) for the patient was started on admission, followed by two weeks.
-
